title: Vaccines, emerging viruses, and how to avoid disaster.
abstract: Rino Rappuoli is a graduate of Siena University, where he also earned his PhD before moving to the Sclavo Research Center, the Italian vaccine institute, also in Siena. He then spent two years in the USA, mostly at Harvard with John Murphy and Alwin Pappenheimer working on a new diphtheria vaccine based on a non-toxic mutant of diphtheria toxin which has since become the basis for conjugate vaccines against haemophilus, meningococcus, and pneumococcal infections, before returning to the Sclavo Research Center where he developed an acellular vaccine based on a mutant pertussis toxin. With many achievements in vaccine development to his credit, he is now Global Head of Vaccines Research and Development for Novartis Vaccines in Siena, and has most recently pioneered reverse vaccinology, in which the genome of the pathogen is screened for candidate antigenic and immunogenic vaccine components. We spoke to him about the potential for outbreaks of the kind we are now seeing with Ebolavirus in West Africa, and what can be done to prevent them.
authors.affiliation: Novartis Vaccines, Siena 53100, Italy. rino.rappuoli@novartis.com.
authors.forename: Rino
authors.initials: R
authors.lastname: Rappuoli
mesh_terms: D021821:Communicable Diseases, Emerging / Q000628:therapy*; D006801:Humans; D014765:Viral Vaccines / Q000627:therapeutic use*; D014780:Viruses / Q000276:immunology*
chemical_list: D014765:Viral Vaccines